Subependymal giant cell astrocytoma

Common Name(s)

Subependymal giant cell astrocytoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Subependymal giant cell astrocytoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Subependymal giant cell astrocytoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Subependymal giant cell astrocytoma" returned 21 free, full-text research articles on human participants. First 3 results:

An unusually aggressive clinical behavior in a case of atypical subependymal giant cell astrocytoma.
 

Author(s): Devi Prasad Patra, Pravin Salunke, Debajyoti Chatterjee, R K Vasishta

Journal: Neurol India. ;62(5):546-8.

 

Last Updated: 12 Nov 2014

Go To URL
Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus.
 

Author(s): Dolly Aguilera, Robert Flamini, Claire Mazewski, Matthew Schniederjan, Laura Hayes, William Boydston, Robert C Castellino, Tobey J MacDonald

Journal: J. Pediatr. Hematol. Oncol.. 2014 Oct;36(7):e448-51.

 

Brain subependymal giant cell astrocytomas (SEGAs) in patients with tuberous sclerosis have been reported to respond to everolimus.

Last Updated: 24 Sep 2014

Go To URL
Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
 

Author(s): Jonathan Roth, E Steve Roach, Ute Bartels, Sergiusz Jóźwiak, Mary Kay Koenig, Howard L Weiner, David N Franz, Henry Z Wang

Journal: Pediatr. Neurol.. 2013 Dec;49(6):439-44.

 

Tuberous sclerosis complex is an autosomal dominant disorder predisposing to the development of benign lesions in different body organs, mainly in the brain, kidney, liver, skin, heart, and lung. Subependymal giant cell astrocytomas are characteristic brain tumors that occur in 10% ...

Last Updated: 25 Nov 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Subependymal giant cell astrocytoma" returned 1 free, full-text review articles on human participants. First 3 results:

Everolimus tablets for patients with subependymal giant cell astrocytoma.
 

Author(s): Scott G Turner, Katherine B Peters, James J Vredenburgh, Annick Desjardins, Henry S Friedman, David A Reardon

Journal: Expert Opin Pharmacother. 2011 Oct;12(14):2265-9.

 

Better understanding of aberrantly active molecular pathways in tumors offers potential to develop more specific and less toxic therapies. Abnormal mammalian target of rapamycin (mTOR) complex signaling and defects in TSC1 and TSC2 have been associated with the development of subependymal ...

Last Updated: 7 Sep 2011

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
 

Status: Recruiting

Condition Summary: Adult Anaplastic Astrocytoma; Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Oligodendroglioma; Adult Pilocytic Astrocytoma; Adult Pineal Gland Astrocytoma; Adult Subependymal Giant Cell Astrocytoma; Recurrent Adult Brain Tumor

 

Last Updated: 11 Aug 2015

Go to URL
Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
 

Status: Recruiting

Condition Summary: Glioblastoma; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; Anaplastic Ependymoma

 

Last Updated: 8 Jan 2015

Go to URL
Phase I Study of Safety and Immunogenicity of ADU-623
 

Status: Recruiting

Condition Summary: Astrocytic Tumors; Glioblastoma Multiforme; Anaplastic Astrocytoma; Brain Tumor

 

Last Updated: 4 Sep 2015

Go to URL